Recently, according to "Regulation of Anhui Enterprise Technology Center Identification" (JXKJ.AH. [2023] 24) and "Notice on Submission and Evaluation of Anhui Enterprise Technology Center " requirements, after the enterprise submission, the initial examination and joint recommendation by the municipal bureau of economic and information, development and reform, science and technology, finance, taxation and customs departments; preliminary evaluation, expert evaluation, comprehensive evaluation, public announcement and other procedures, determined that Anhui Poly and other 263 enterprise technology centers as the Anhui Enterprise Technology Center in 2023 (32nd batch), and announced the list:Anhui Poly, a wholly owned subsidiary of Hainan Poly Pharm., has been included in the list of Anhui Enterprise Technology Center in 2023 (32nd batch).
According to "Regulation of Anhui Enterprise Technology Center Identification" (JXKJ.AH. [2023] 24) and "Notice on Submission and Evaluation of Anhui Enterprise Technology Center " requirements, after the enterprise submission, the initial examination and joint recommendation by the municipal bureau of economic and information, development and reform, science and technology, finance, taxation and customs departments; preliminary evaluation, expert evaluation, comprehensive evaluation, public announcement and other procedures, determined that Anhui Poly and other 263 enterprise technology centers as the Anhui Enterprise Technology Center in 2023 (32nd batch), and announced the list:Anhui Poly was included in the list of Anhui Provincial Enterprise Technology Center in 2023 (32nd batch).
Anhui Poly Pharm. is a professional supplier of API, dedicated to providing chemically synthetic, biosynthetic and high-quality raw materials and services in fields of pharmaceutical industry, health care and skin care worldwide.
Relying on the strong R&D capability and technology conversion ability, we have completed the commercialization of contrast media (gadoterate meglumine, gadoteridol, gadobutrol, iomeprol, iopromide, ioversol, iopamidol, iodixanol, etc.), synthetic biology ( ectoin, salidroside, ursodeoxycholic acid, etc.), anti-tumor (cyclophosphamide, etc.), other APIs (magnesium hydroxide, apremilast, crisaborole, voriconazole, memantine hydrochloride, etc.), other pharmaceutical excipients (DOTA, Sulfobutylether-β-Cyclodextrin, calteridol calcium, calcobutrol, etc.), and other series of products, and their commercial development, production, and global registration.
Anhui Poly Pharm. adheres to the corporate tenet of “Good Drug product, Healthy People”, carries out the core values of "Integrity, Efficiency, Innovation and Professionalism", and commits to becoming a leader in the field of specialty APIs.Poly Pharm. always adheres to the customer demand-oriented, quality as the core, with leading technology to build the extraordinary road to the international high-end API suppliers.
